Filter
441
Text search:
pharmaceutical
management
cycle
Featured
Recommendations
40
New Publications
140
Language
Document type
No document type
235
Studies & Reports
75
Guidelines
56
Manuals
30
Strategic & Response Plan
29
Training Material
6
Fact sheets
5
Situation Updates
3
Resource Platforms
2
Countries / Regions
Ethiopia
23
India
23
Kenya
19
Global
19
Uganda
12
Nepal
10
South Africa
10
Western and Central Europe
9
Nigeria
8
Zambia
8
Tanzania
8
Namibia
8
Liberia
7
Ghana
7
Philippines
7
Sierra Leone
6
Rwanda
6
Indonesia
6
Africa
5
Zimbabwe
4
Bangladesh
4
Malawi
4
Ukraine
4
Cameroon
3
South Sudan
3
Syria
3
Cambodia
3
Eswatini/ Swaziland
3
Myanmar / Burma
3
Eastern Europe and Central Asia
3
Eastern Europe
3
Burkina Faso
2
Senegal
2
Pakistan
2
Jordan
2
Thailand
2
Mozambique
2
Lesotho
2
East and Southern Africa
2
West and Central Africa
2
South–East Asia Region
2
Fiji
2
Laos
2
Vietnam
2
Congo, Democratic Republic of
1
USA
1
Haiti
1
Somalia
1
Iraq
1
Lebanon
1
Egypt
1
Sudan
1
Benin
1
Central African Republic
1
Brazil
1
Botswana
1
Libya
1
Middle East and North Africa
1
Latin America and the Carribbean
1
Albania
1
Timor Leste/ East Timor
1
Lithuania
1
Moldova
1
Australia
1
Authors & Publishers
Publication Years
Category
Countries
205
Clinical Guidelines
25
Key Resources
24
Public Health
13
Pharmacy & Technologies
8
Women & Child Health
7
Capacity Building
5
Toolboxes
Pharmacy
48
AMR
35
COVID-19
21
NTDs
20
HIV
19
TB
19
Mental Health
17
Planetary Health
17
Rapid Response
12
Conflict
7
Health Financing Toolbox
7
Ebola
6
Caregiver
6
NCDs
6
Global Health Education
5
Disability
4
Specific Hazards
4
Refugee
3
Natural Hazards
2
Zika
1
A call for national and regional containment, recovery and prevention
Oxfam Briefing Paper
2nd edition .
This Framework applies to the sharing of H5N1 and other influenza viruses with human pandemic potential and the sharing of benefits. This Framework does not apply to seasonal influenza viruses or other non-influenza pathogens or biological substances that may be contained in clinical
...
A manual for developing national action plans.This manual for developing national action plans to address antimicrobial resistance has been developed at the request of the World Health Assembly to assist countries in the initial phase of developing new, or refining existing national action plans in
...
Notable progress has also been made on other key health indicators such as reducing maternal, infant and child deaths and malnutrition, increasing immunization coverage, eliminating infectious diseases such as polio and reducing the incidence of malaria, tuberculosis and diarrhoeal diseases.
But
...
The 2014–2015 Ebola epidemic in western Africa was the longest and most deadly Ebola epidemic in history, resulting in 28,616 cases and 11,310 deaths in Guinea, Liberia, and Sierra Leone. The Ebola virus has been known since 1976, when two separate outbreaks were identified in the Democratic Repub
...
Guideline ‒ Alternative mass drug administration regimens to eliminate lymphatic filariasis
recommended
Lymphatic filariasis is a vector-borne neglected tropical disease that causes damage of the lymphatic system and can lead to lymphoedema (elephantiasis) and hydrocele in infected individuals. The global baseline estimate of persons affected by lymphatic filariasis is 25 million men with hydrocele an
...
Guidelines for social mobilization
TB and poverty; TB and children; TB and women; TB, migrants and refugees; TB and prisons
WHO/CDS/STB/2001.9
Original: English; Distribution: Limited